Findings
========

Porcine reproductive and respiratory syndrome (PRRS) is an economically important viral pig disease in swine producing countries worldwide. The virus can cause reproductive disorders and can give rise to respiratory problems in pigs of all ages \[[@B1]\]. Prevention of the disease is based on a combination of management and vaccination. Evidence is accumulating that PRRSV heterogeneity is affecting the vaccination efficiency. It is suggested that vaccines are only efficacious when the vaccine virus and the challenge virus share a sufficiently high homology \[[@B2]-[@B6]\]. PRRSV heterogeneity was originally considered mainly to occur between European (genotype 1) and American type (genotype 2) PRRSV, but current understanding shows a more complex situation with considerable genetic variability within genotypes \[[@B7]-[@B9]\]. Since such variability may affect the efficacy of vaccination programs and pose an obstacle for PRRSV prevention and control, knowledge on the PRRSV strains circulating on a farm may be essential for choosing an appropriate vaccine \[[@B10]\].

PRRSV diagnosis is mainly based on detection of PRRSV antibodies, Reverse Transcriptase (RT) PCR or virus isolation. Detection of antibodies by ELISA or IPMA is not sufficient to establish the level of PRRSV heterogeneity \[[@B11]\]. RT-PCR allows rapid detection and genotyping of PRRSV, but the high degree of sequence variation observed for PRRSV can influence results obtained by (real-time) RT-PCR and primers and/or probes should be carefully designed based on conserved regions \[[@B8],[@B12]\]. The development of sequence-independent PCR techniques could be useful for the diagnosis and genotyping of unknown PRRSV isolates and for assessment of the PRRSV heterogeneity of field isolates. Several methods have been developed for the identification of viruses without prior sequence knowledge \[[@B13]\]. For instance, whole genome amplification and random PCR are relatively simple. In both these methods, viral particles (from biological samples or cell culture) are treated with DNAse and RNAse to remove contaminating nucleic acids. RNA and/or DNA from the viral particles is extracted and RNA is reverse transcribed to cDNA using a primer with a random 3\'end. Subsequently, cDNA or viral DNA is amplified using a shorter primer (without the 3\' random end). This results in DNA fragments of varying size (e.g. 0.5 - 2 Kb) and these fragments can be cloned and sequenced. For instance Allander *et al.*\[[@B14]\] used random PCR on human respiratory tract samples which allowed identification of several unknown viruses.

The aim of this study was to test a random PCR cloning technique \[[@B14]\] for the detection and genotyping of a PRRSV strain of unknown genetic background.

Random PCR cloning for the identification of PRRSV 07V063
---------------------------------------------------------

PRRSV 07V063 was isolated from an aborted foetus from a Belgian farm, by inoculation of porcine alveolar macrophages. On this farm, vaccination with Porcilis™ was in place. PRRS diagnosis was confirmed upon detection of cytopathic effect (CPE), and detection of PRRSV antigens by IPMA staining with the nucleocapsid specific mAb P3/27 \[[@B15]\]. The use of a random PCR approach abrogates the need for *a priori*sequence information and in combination with small scale shotgun sequencing, this can result in viral sequences. Virus 07V063 was grown on MARC-145 cells and concentrated as described \[[@B16]\] and the viral pellet was treated with DNAseI and RNAse. RNA was extracted using commercial kits and used in reverse transcription and random amplification using the tagged random hexanucleotide 5\'-GCCGGAGCTCTGCAGATATCNNNNNN-3\' for both first- and second strand cDNA synthesis and subsequent amplification of the cDNA with primer 5\'-GCCGGAGCTCTGCAGATATC-3\' \[[@B14]\]. Random PCR fragments ranging between 500 and 1200 bp were cloned in pCR-Blunt II-TOPO (Invitrogen). Twenty nine clones were sequenced as described \[[@B17]\]. Twenty three clones (80% of the clones) contained PRRS sequences (Table [1](#T1){ref-type="table"}). The six other clones showed no match when performing BlastN <http://www.ncbi.nlm.nih.gov>. The 07V063 sequences were randomly distributed across the PRRSV genome. Several clones were overlapping and six contigs (with sizes between 622 and 2072 bp) were obtained (Figure [1](#F1){ref-type="fig"}). Thus, without prior knowledge of the sequence it was possible to obtain 7305 bp sequence data using a random PCR cloning approach, hereby confirming PRRS identity.

###### 

Overview of the sequences from 07V063 obtained by random PCR cloning.

  Clone   Size (nt)   Position      \% nt identity
  ------- ----------- ------------- ----------------
  49      671         774-1444      81
  73      198         1692-1889     89
  104     826         1808-2633     89
  20      798         2616-3413     86
  105     375         3069-3443     88
  88      429         3420-3847     93
  33      332         3957-4288     91
  92      316         6198-6512     93
  61      713         6367-7079     93
  103     312         6768-7079     94
  35      364         6500-6863     93
  12      247         8132-8378     89
  51      627         8931-9557     86
  80      358         9200-9557     87
  82      622         11225-11846   87
  11      258         11225-11482   86
  81      601         11928-12528   92
  70      189         12336-12524   94
  40      277         12364-12640   90
  78      395         12991-13385   90
  57      935         13195-14129   91

The position of the sequences is indicated relative to LV. % nt identity is with LV.

![**PRRSV genome and position of the contigs**. The sequences obtained in the random PCR cloning approach were assembled in six contigs (with sizes between 622 and 2072 bp) dispersed over the genome. The contigs are shown with a line.](1743-422X-8-160-1){#F1}

Full length sequence of 07V063 and comparison with prototype LV
---------------------------------------------------------------

To allow a more detailed evaluation of the PRRSV isolate 07V063, the full length genome sequence was obtained using primers that were based on the 07V063 sequences from the random PCR cloning approach (Table [2](#T2){ref-type="table"}). Overlapping amplicons (spanning the complete genome) were obtained using RT-PCR. Both strands of these fragments were directly sequenced. For the amplification of the 3\'end, oligodT was used in combination with ORF7fw. A 5\' end primer (5\'endfw) was designed based on the alignment of genotype 1 strains LV ([M96262](M96262)), EuroPRRS ([AY366525](AY366525)), SD01-08 ([DQ489311](DQ489311)), KNU-07 ([FJ349261](FJ349261)) and HKEU16 ([EU076704](EU076704)). This primer was used in combination with primer Lavgsprev to amplify the 5\'end. A full length sequence of 15014 nt was obtained. This sequence was deposited in Genbank (Accession [GU737264](GU737264)).

###### 

Oligonucleotide primers used in RT-PCR amplification and nucleotide sequencing of 07V063

  Primer          Sequence                      Position
  --------------- ----------------------------- -------------
  5\'endFW        atgatgtgtagggtattccccc        1-22
  Orf1univFW      ccctttaaccatgtctggc           111-130
  Orf1-1fw        catcc gggtg ctgctgg ctt       336-355
  Orf1-2fw        ggag ccaccc acgtgtt gac       681-701
  Lav49fw         aatcaatggtattcgtgctg          1072-1091
  Orf1-3-fw       tcaat gcctacaa ctgcccg        1631-1650
  Orf1-4-fw       cttgta taaa ttgct attgg       1988-2007
  Orf1-5-fw       acaa cagg cctc gtaa ggg       2472-2490
  Lav73fw         aaaacttggcgctgcacgtc          3102-3121
  Orf1-6fw        ggtcc atta gcca gcgcct        3451-3469
  Orf1-7fw        cttgag cagcg ccaa cattg       3686-3705
  Lav33fw         ggtgttggcacggcgagag           4129-4147
  Orf1-8fw        catgg ctgtt gccca agtgt       4538-4557
  Orf1-9fw        ttgt gctt acgcc tggccca       4859-4878
  Orf1-10fw       ggcgac tcct ataat cgtat       5364-5383
  Orf1-11fw       ccaa gcac ttcg cagg tccg      5701-5720
  Orf1-12fw       ggctt ggctg ccgaaa tcgg       6096-6115
  Orf1-13fw       aatgaa gggag tctt gtcta       6566-6586
  Lav92fw         gtgtatccctcggctaccac          6891-6911
  Orf1-14fw       catta gtcaa cttcaa ggtt       7280-7299
  Orf1-15fw       gga ccc tga gcgg catgaa       7765-7783
  Lav12fw         ccaagaactccatggcaggt          8172-8191
  Orf1-16fw       ggaaaaacaaattcaaggag          8442-8461
  Orf1-17fw       tccag cccatg ctggt ata        8817-8835
  Lav51fw         gtgtttgtttcactcacact          9316-9335
  Amp6fwint       catcagaccatgtttgacat          9764-9783
  Orf1-18fw       aaggc caggaa cacca gggt       10136-10155
  Orf1-19fw       cccagta tttgca ccttt gc       10633-10652
  Orf1-20fw       cggccgta cttgc aaccag         11132-11150
  Orf2afw         gts aca cck tat gatta cg      11387-11406
  LavORF2aseqfw   gtgttcgacaacgcccacacgc        11577-11598
  Orf3fw          agcc taca gta caa ca ccac     12234-12253
  LavORF3seq1fw   agcgttgagctcatcttccc          12261-12280
  Orf4fw          cgg ccc ait tcc atccigag      12672-12691
  Orf5Pesfw       tga tca cat tcg gtt gct       13320-13337
  Orf6fw          tacc aa ctt tc ttc tggac      13838-13856
  Orf7fw          tgg cccc tgccc aic acg        14328-14345
  Orf1-1-rev      gtcaa cacgt gggtgg ctcc       701-681
  Lavgsprev       cgacttgacattctagtcca          900-881
  Orf1-2-rev      agat gcca aacgg acgaa cc      1304-1285
  Orf1-3-rev      gcag cctt cgga gcag acgc      1796-1777
  ORF1-4-rev      cggtg aaca cgag acacc tg      2252-2233
  Orf1-5-rev      gctg atgt tgtc ggatt ctg      2615-2596
  Orf1-6-rev      ctggg aaca ggagg cgg tgt      3202-3182
  Orf1-7-rev      gggttgg atg gagtc gagaa       3730-3711
  Lav33rev        ccccaacacttgtgacaacg          3982-3963
  Orf1-8rev       gt ccgag tccac tacaatc        4403-4385
  Orf1-9rev       agag ttgt gccac tgct gaaa     4755-4735
  Amp3intrev2     cagagaaggccggttattcct         5023-5003
  Amp3intrev      gattccaatgagatcacca           5609-5591
  Orf1-10rev      gctc ggac taaaa cagc tgg      5959-5940
  Lav92rev        caccaatgatgatgataggg          6222-6203
  Orf1-11rev      cttg caca gaca cagtttt        6720-6702
  Orf1-12rev      ttcaa ggca gttg tca ggct      7190-7171
  Orf1-13rev      tca ttaa gacg acacc ggaa      7406-7386
  Orf1-14rev      cttg ccat cgga cacaa gg       7903-7885
  Orf1-15rev      tga cacc actg agcg ccga       8396-8378
  Orf1-16rev      agaca cact ggtg acggggt       8696-8676
  Lav51rev        aagaaagctgggtttgtcag          8971-8952
  Orf1-17rev      cggaa tctg tttcaa cacag       9460-9441
  Orf1-18rev      ccagg tggtt gcaa tatcca       9944-9925
  Orf1-19rev      aaaactccc gaag ttggtcg        10385-10366
  Orf1-20rev      aggc ttgc tgtag tgggcat       10762-10743
  Lav82rev        ttcaagctggaagtaggc            11244-11225
  Orf1-21rev      tgatttt gctcc acag tgac       11741-11722
  Orf2arev        tcatr ccc tatt y tgc acca     12558-12539
  Orf3rev         agaa aa gg cacgc ag aaa gca   13184-13165
  Orf4rev         cattcagctcgcataicgtcaag       13569-13547
  Orf5Pesrev      ggg cgt ata tca tta tag gtg   14100-14079
  Orf6rev         acccagc aa ctgg cacag         14606-14589
  Orf7rev         tcg ccc taa ttg aa tagg tga   14966-14946

The 5\' end and 3\'end of 07V063 was 221 nt and 114 nt, respectively. The size of the 5\'end of 07V063 is identical with the 5\'end of LV with 92.3% identity and 17 nt differences. Several motifs such as the transcription regulatory sequence (UUAACC) and CACCC stretches (involved in binding of host cell transcription factors) are conserved in 07V063 \[[@B18]\]. Table [3](#T3){ref-type="table"} gives an overview of all ORFs in the 07V063 genome and comparison with ORFs from prototype LV. Most variation with LV was noticed in Nsp1 (85% identity/91% similarity) and Nsp2 (81% identity/85% similarity). A major difference is a deletion of 28 aa in a variable region of Nsp2 (at positions 683-710). Similar deletions in this region are known e.g. EuroPRRS has a 17 aa deletion (Figure [2A](#F2){ref-type="fig"}; \[[@B18]\]). The deletion in NSP2 in 07V63 could be a unique marker for this strain.

###### 

Comparison of proteins from 07V63 and prototype LV

  *ORF*   *Protein*   *Size 07V63*   *Size LV*   *% identity*   *% similarity*
  ------- ----------- -------------- ----------- -------------- ----------------
  *1a*    Nsp1        *385*          *385*       *85*           *91*
          Nsp2        833            861         81             85
          Nsp3        447            447         93             96
          Nsp4        203            203         92             96
          Nsp5        170            170         96             97
          Nsp6        16             16          100            100
          Nsp7        269            269         96             97
          Nsp8        45             45          100            100
  1b      Nsp9        645            645         96             98
          Nsp10       442            442         94             97
          Nsp11       224            224         95             97
          Nsp12       152            152         93             96
  2a      GP2         249            249         93             94
  2b      E           70             70          95             97
  3       GP3         265            265         89             92
  4       GP4         183            183         87             93
  5       GP5         200            201         91             94
  6       M           173            173         93             94
  7       N           128            128         91             98

![**Alignment of Nsp2, ORF4 and ORF5 proteins from 07V063 with LV (ORF4 and ORF5) and a selection of genotype 1 strains (Nsp2)**. A. Alignment of Nsp2 proteins from genotype 1 strains. Only aa positions 636-755 (LV) are shown. The deletion in 07V063 is located at aa positions 683-710. B. Alignment of GP4 from 07V063 and LV (only the first 120 aa are shown). A neutralizing epitope in LV (57-68) is underlined. C. Alignment of GP5 from 07V063 and LV. A neutralizing epitope in North American strains (37-45) is underlined.](1743-422X-8-160-2){#F2}

Strain 07V063 showed 87 - 95% aa identity with LV for the structural ORFs 2 - 7. We compared GP4 and GP5 proteins from 07V063 and LV since it has been shown that these proteins are the main target for neutralizing antibodies. Figure [2B](#F2){ref-type="fig"} shows an alignment of ORF4 proteins. Notably is the high variation in the region 50-70. It has been shown that a neutralizing epitope is present in LV at positions 57-68 \[[@B19]\] and that this region is under antibody-mediated pressure *in vitro*and *in vivo*\[[@B20],[@B21]\]. Pigs infected with 07V063 produce neutralizing antibodies against the ^57^RVTAAQGRIYTR^68^epitope. However, these antibodies do not cross-protect against LV \[[@B22]\]. Similarly, antibodies against the same region in LV, do not cross-protect against 07V063. Interestingly, this lack of cross-neutralization is in agreement with the finding that strain 07V063 was able to replicate and cause disease on a farm where animals were vaccinated with the LV-like Porcilis™ vaccine.

GP5 has been described as the main target for virus-neutralizing antibodies in North American PRRSV strains. A neutralizing epitope has been identified at positions 37-45 \[[@B23]\]. Figure [2C](#F2){ref-type="fig"} shows that 07V063 and LV have an identical sequence from 37-45 with the exception of an extra glycosylation site at position 37 in 07V063. It has been shown that several strains are glycosylated at this position but the significance of this glycosylation is not known. Other amino acid changes occur throughout the sequence and several of these positions have been described as variable \[[@B24]\]. No other differences in glycosylation pattern of the structural proteins between 07V063 and LV was observed.

Phylogenetic relationship of 07V063
-----------------------------------

Since ORF5 is frequently used as a marker for the study of genetic relationships \[[@B8]\], we constructed phylogenetic trees using ORF5 sequences from a selection of genotype 1 strains (Table [4](#T4){ref-type="table"}). In addition genotype 1 strains for which the full length sequence was available in Genbank were included. VR-2332 (genotype 2) was used as out-group.

###### 

Overview of strains used for phylogenetic analysis

  Strain     Genotype        Genbank Accession ORF5   Genbank Accession ORF1a (nsp2)
  ---------- --------------- ------------------------ --------------------------------
  VR-2332    2               [U87392](U87392)         [U87392](U87392)
  Lelystad   1 (subtype 1)   [M96262](M96262)         [M96262](M96262)
  EuroPRRS   1               [AY366525](AY366525)     [AY366525](AY366525)
  01-CB1     1 (subtype 1)   [DQ864705](DQ864705)     [DQ864705](DQ864705)
  Amervac    1 (subtype 1)   [GU067771](GU067771)     [GU067771](GU067771)
  HKEU16     1 (subtype 1)   [EU076704](EU076704)     [EU076704](EU076704)
  KNU-07     1 (subtype 1)   [FJ349261](FJ349261)     [FJ349261](FJ349261)
  SHE        1 (subtype 1)   [GQ461593](GQ461593)     [GQ461593](GQ461593)
  SD01-08    1 (subtype 1)   [DQ489311](DQ489311)     [DQ489311](DQ489311)
  BJEU06-1   1 (subtype 1)   [GU047344](GU047344)     [GU047344](GU047344)
  NMEU09-1   1 (subtype 1)   [GU047345](GU047345)     [GU047345](GU047345)
  07V063     1 (subtype 1)   [GU737264](GU737264)     [GU737264](GU737264)
                                                      
  PyrsVac    1 (subtype 1)   [DQ324681](DQ324681)     ND
  Porcilis   1 (subtype 1)   [AAW78901](AAW78901)     ND
  Olot/91    1 (subtype 1)   [X92942](X92942)         ND
  Yuz-34     1 (subtype 3)   [DQ324692](DQ324692)     ND
  Bel-42     1 (subtype 3)   [DQ324669](DQ324669)     ND
  Obu-1      1 (subtype 3)   [DQ324671](DQ324671)     ND
  Soz-6      1 (subtype 3)   [DQ324686](DQ324686)     ND
  Dzi-62     1 (subtype 1)   [DQ324675](DQ324675)     ND
  Cresa11    1 (subtype 1)   [DQ009626](DQ009626)     ND
  IV3140     1 (subtype 1)   [DQ355821](DQ355821)     ND
  28639/98   1 (subtype 1)   [AY035912](AY035912)     ND
  361-4      1 (subtype 1)   [AY035915](AY035915)     ND
  Sno-4      2 (subtype 2)   [DQ324683](DQ324683)     ND
  Sid        2 (subtype 2)   [DQ324682](DQ324682)     ND
  Aus        2 (subtype 2)   [DQ324667](DQ324667)     ND
  Okt-35     1               [DQ324677](DQ324677)     ND
  16/2000    1               [DQ345743](DQ345743)     ND
  SD02-11    1 (subtype 1)   [AY395078](AY395078)     [AY383634](AY383634)
  SD01-07    1 (subtype 1)   [AY395079](AY395079)     [AY383632](AY383632)
  SD03-12    1 (subtype 1)   [AY395074](AY395074)     [AY383635](AY383635)
  SD03-15    1 (subtype 1)   [AY395076](AY395076)     [AY383636](AY383636)
  It-22      1 (subtype 1)   [AY739978](AY739978)     ND
  It-39      1 (subtype 1)   [AY739995](AY739995)     ND
  It-44      1 (subtype 1)   [AY740000](AY740000)     ND
  It-35      1 (subtype 1)   [AY739991](AY739991)     ND
  It-13      1 (subtype 1)   [AY739969](AY739969)     ND
  Lena       1 (subtype 3)   [EU909691](EU909691)     ND

The type of the strains is according to Stadejek et al (2008). ND = no data. VR-2332 is genotype 2. Eleven genotype 1 isolates for which full length sequences were obtained are listed first.

Figure [3A](#F3){ref-type="fig"} shows a phylogenetic tree of ORF5 DNA sequences based on the Neighbour Joining (NJ) method. Several clusters are evident and supported by high bootstrap values. It can be concluded that 07V063 clusters within the pan-European subtype 1 \[[@B8]\]. Within subtype 1, a cluster with LV- and Olot/91-like strains can be distinguished. Although both LV and Olot/91 belong to the earliest PRRSV isolates, still LV and Olot/91-like strains such as SD01-08 are circulating. Strain 07V063 is genetically different from LV- and Olot/91- like strains. Apparently 07V063 clusters together with isolates from different geographical locations e.g. isolates from Spain (16/2000), Denmark (361-4), China (BJEU06-1) and South-Korea (IV3140) although this clustering is not supported by high bootstrap values. A similar tree topology was obtained using ORF5 protein sequences (data not shown). The sub-clustering of type 1 is complex and cannot always be explained by geographic isolation of the strains \[[@B8]\]. The sequence of 07V63 adds to the increase of genetic diversity of type 1 strains and is an example of continuous genetic drift within PRRSV \[[@B24]\]. A recent PRRSV study in Spain \[[@B25]\] demonstrated that Spanish isolates from different years show continuous evolution and increase in heterogeneity and that different genotypes and variants within the genotypes co-circulate.

![**Phylogenetic relationship of 07V063**. Phylogenetic trees were derived from multiple sequence alignments using Phylip v3.67. Bootstrapping was performed 500 times using SEQBOOT. Pairwise distances between DNA and/or protein sequences were determined with DNAdist and PROTdist, respectively. Neighbour-Joining (NJ) trees were calculated with NEIGHBOUR and Maximum Likelyhood (ML) trees with DNAML and PROML. Majority rule consensus trees were calculated using CONSENSE. The percentage confidence is indicated on the branches (500 datasets). Trees, constructed using NJ method, based on ORF5 DNA (A) or ORF1a (Nsp2) DNA (B) sequences. Strain 07V063 is underlined. VR-2332 was used as outgroup.](1743-422X-8-160-3){#F3}

Also, phylogenetic trees using Nsp2 were constructed (Figure [3B](#F3){ref-type="fig"}). Sequences from all known full length genotype 1 strains (Table [4](#T4){ref-type="table"}) were included. Essentially, the same topology can be observed as for ORF5. A cluster of LV-like strains is evident and supported by high bootstrap values. As was already observed from the ORF5 phylogenetic tree, Amervac and SHE are very closely related as is the case for strains 01-CB1 and LV. 07V063 clusters apart from LV and is genetically distinct from the LV prototype.

Conclusions
===========

By using a simple random PCR cloning approach we obtained PRRSV sequence data from a recent European PRRSV isolate of unknown genetic background. This approach can be used to obtain partial genome sequences from for instance East-European type strains (for which until present, no full length genomes are available) and to get a better knowledge of the increasing PRRSV variability. We also showed that the isolate sequenced in this study is genetically different from prototype LV.
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